{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:23:42Z","timestamp":1793291022257,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00467-020-04811-0","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T18:03:27Z","timestamp":1603908207000},"page":"1175-1182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["A global antiB cell strategy combining obinutuzumab and daratumumab in severe pediatric nephrotic syndrome"],"prefix":"10.1007","volume":"36","author":[{"given":"Claire","family":"Dossier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Prim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e9sa","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Maisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"De Gennes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Barsotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelmajid","family":"Bourrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5158-2915","authenticated-orcid":false,"given":"Georges","family":"Desch\u00eanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,28]]},"reference":[{"key":"4811_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00467-018-4149-2","volume":"34","author":"C Dossier","year":"2019","unstructured":"Dossier C, Delbet JD, Boyer O, Daoud P, Mesples B, Pellegrino B, See H, Benoist G, Chace A, Larakeb A, Hogan J, Deschenes G (2019) Five-year outcome of children with idiopathic nephrotic syndrome: the NEPHROVIR population-based cohort study. Pediatr Nephrol 34:671\u2013678","journal-title":"Pediatr Nephrol"},{"key":"4811_CR2","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1053\/ajkd.2003.50116","volume":"41","author":"F Fakhouri","year":"2003","unstructured":"Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Grunfeld JP, Niaudet P (2003) Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis 41:550\u2013557","journal-title":"Am J Kidney Dis"},{"key":"4811_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.05000516","volume":"12","author":"M Vivarelli","year":"2017","unstructured":"Vivarelli M, Massella L, Ruggiero B, Emma F (2017) Minimal change disease. Clin J Am Soc Nephrol 12:332\u2013345","journal-title":"Clin J Am Soc Nephrol"},{"key":"4811_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00467-011-1830-0","volume":"26","author":"S Azib","year":"2011","unstructured":"Azib S, Macher MA, Kwon T, Dechartres A, Alberti C, Loirat C, Deschenes G, Baudouin V (2011) Cyclophosphamide in steroid-dependent nephrotic syndrome. Pediatr Nephrol 26:927\u2013932","journal-title":"Pediatr Nephrol"},{"key":"4811_CR5","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","volume":"384","author":"K Iijima","year":"2014","unstructured":"Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y (2014) Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 384:1273\u20131281","journal-title":"Lancet"},{"key":"4811_CR6","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/ndt\/gfr405","volume":"27","author":"AL Sellier-Leclerc","year":"2012","unstructured":"Sellier-Leclerc AL, Baudouin V, Kwon T, Macher MA, Guerin V, Lapillonne H, Deschenes G, Ulinski T (2012) Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery. Nephrol Dial Transplant 27:1083\u20131089","journal-title":"Nephrol Dial Transplant"},{"key":"4811_CR7","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00467-011-1825-x","volume":"26","author":"A Zagury","year":"2011","unstructured":"Zagury A, de Oliveira AL, de Moraes CA, de Araujo Montalvao JA, Novaes RH, de Sa VM, Monteiro de Carvalho DB, Matuck T (2011) Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndrome. Pediatr Nephrol 26:915\u2013920","journal-title":"Pediatr Nephrol"},{"key":"4811_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/ar2780","volume":"11","author":"T Dorner","year":"2009","unstructured":"Dorner T, Jacobi AM, Lipsky PE (2009) B cells in autoimmunity. Arthritis Res Ther 11:247","journal-title":"Arthritis Res Ther"},{"key":"4811_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13075-015-0603-8","volume":"17","author":"T Fassbinder","year":"2015","unstructured":"Fassbinder T, Saunders U, Mickholz E, Jung E, Becker H, Schluter B, Jacobi AM (2015) Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus. Arthritis Res Ther 17:92","journal-title":"Arthritis Res Ther"},{"key":"4811_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4049\/jimmunol.180.1.361","volume":"180","author":"DJ DiLillo","year":"2008","unstructured":"DiLillo DJ, Hamaguchi Y, Ueda Y, Yang K, Uchida J, Haas KM, Kelsoe G, Tedder TF (2008) Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice. J Immunol 180:361\u2013371","journal-title":"J Immunol"},{"key":"4811_CR11","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.kint.2019.12.025","volume":"97","author":"E Crickx","year":"2020","unstructured":"Crickx E, Weill J, Reynaud C, Mah\u00e9vas M (2020) Anti-CD20-mediated B-cell depletion in auto-immune diseases: successes, failures and future perspectives. Kidney Int 97:885\u2013893","journal-title":"Kidney Int"},{"key":"4811_CR12","first-page":"151","volume":"73","author":"RW Blumberg","year":"1947","unstructured":"Blumberg RW, Cassady HA (1947) Effect of measles on the nephrotic syndrome. Am J Dis Child 73:151\u2013166","journal-title":"Am J Dis Child"},{"key":"4811_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/adc.53.5.363","volume":"53","author":"D Gairdner","year":"1978","unstructured":"Gairdner D (1978) A notable case of nephrosis. Arch Dis Child 53:363\u2013365","journal-title":"Arch Dis Child"},{"key":"4811_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1126\/science.aay6485","volume":"366","author":"MJ Mina","year":"2019","unstructured":"Mina MJ, Kula T, Leng Y, Li M, de Vries RD, Knip M, Siljander H, Rewers M, Choy DF, Wilson MS, Larman HB, Nelson AN, Griffin DE, de Swart RL, Elledge SJ (2019) Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science 366:599\u2013606","journal-title":"Science"},{"key":"4811_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/bjh.15232","volume":"182","author":"CL Freeman","year":"2018","unstructured":"Freeman CL, Sehn LH (2018) A tale of two antibodies: obinutuzumab versus rituximab. Br J Haematol 182:29\u201345","journal-title":"Br J Haematol"},{"key":"4811_CR16","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1111\/trf.15539","volume":"59","author":"L Cooling","year":"2019","unstructured":"Cooling L, Hugan S (2019) Daratumumab in combination with standard treatment for autoimmune hemolytic anemia in a pediatric patient. Transfusion 59:3801\u20133802","journal-title":"Transfusion"},{"key":"4811_CR17","doi-asserted-by":"publisher","first-page":"e28010","DOI":"10.1002\/pbc.28010","volume":"67","author":"E Even-Or","year":"2020","unstructured":"Even-Or E, Naser Eddin A, Shadur B, Dinur Schejter Y, Najajreh M, Zelig O, Zaidman I, Stepensky P (2020) Successful treatment with daratumumab for post-HSCT refractory hemolytic anemia. Pediatr Blood Cancer 67:e28010","journal-title":"Pediatr Blood Cancer"},{"key":"4811_CR18","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1681\/ASN.2018121254","volume":"30","author":"J Kwun","year":"2019","unstructured":"Kwun J, Matignon M, Manook M, Guendouz S, Audard V, Kheav D, Poullot E, Gautreau C, Ezekian B, Bodez D, Damy T, Faivre L, Menouch D, Yoon J, Park J, Belhadj K, Chen D, Bilewski AM, Yi JS, Collins B, Stegall M, Farris AB, Knechtle S, Grimbert P (2019) Daratumumab in sensitized kidney transplantation: potentials and limitations of experimental and clinical use. J Am Soc Nephrol 30:1206\u20131219","journal-title":"J Am Soc Nephrol"},{"key":"4811_CR19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa1714678","volume":"378","author":"MV Mateos","year":"2018","unstructured":"Mateos MV, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Kaplan P, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Shelekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Chiu C, Wang J, Carson R, Crist W, Deraedt W, Nguyen H, Qi M, San-Miguel J (2018) Daratumumab plus bortezomib, melphalan, and prednisone for untreated myeloma. N Engl J Med 378:518\u2013528","journal-title":"N Engl J Med"},{"key":"4811_CR20","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1681\/ASN.2012121200","volume":"24","author":"J Gellermann","year":"2013","unstructured":"Gellermann J, Weber L, Pape L, Tonshoff B, Hoyer P, Querfeld U (2013) Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol 24:1689\u20131697","journal-title":"J Am Soc Nephrol"},{"key":"4811_CR21","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1093\/ndt\/gfq318","volume":"25","author":"K Ishikura","year":"2010","unstructured":"Ishikura K, Yoshikawa N, Hattori S, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Yata N, Ando T, Honda M (2010) Treatment with microemulsified cyclosporine in children with frequently relapsing nephrotic syndrome. Nephrol Dial Transplant 25:3956\u20133962","journal-title":"Nephrol Dial Transplant"},{"key":"4811_CR22","doi-asserted-by":"publisher","first-page":"102466","DOI":"10.1016\/j.autrev.2020.102466","volume":"19","author":"K Kridin","year":"2020","unstructured":"Kridin K, Ahmed AR (2020) Post-rituximab immunoglobulin M (IgM) hypogammaglobulinemia. Autoimmun Rev 19:102466","journal-title":"Autoimmun Rev"},{"key":"4811_CR23","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1007\/s00467-013-2485-9","volume":"28","author":"AL Sellier-Leclerc","year":"2013","unstructured":"Sellier-Leclerc AL, Belli E, Guerin V, Dorfmuller P, Deschenes G (2013) Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome. Pediatr Nephrol 28:1875\u20131879","journal-title":"Pediatr Nephrol"},{"key":"4811_CR24","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3389\/fimmu.2019.01653","volume":"10","author":"M Colucci","year":"2019","unstructured":"Colucci M, Carsetti R, Serafinelli J, Rocca S, Massella L, Gargiulo A, Lo Russo A, Capponi C, Cotugno N, Porzio O, Onetti Muda A, Palma P, Emma F, Vivarelli M (2019) Prolonged impairment of immunological memory after anti-CD20 treatment in pediatric idiopathic nephrotic syndrome. Front Immunol 10:1653","journal-title":"Front Immunol"},{"issue":"Suppl 8","key":"4811_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/jdv.16025","volume":"33","author":"EI Plasmeijer","year":"2019","unstructured":"Plasmeijer EI, Sachse MM, Gebhardt C, Geusau A, Bouwes Bavinck JN (2019) Cutaneous squamous cell carcinoma (cSCC) and immunosurveillance - the impact of immunosuppression on frequency of cSCC. J Eur Acad Dermatol Venereol 33(Suppl 8):33\u201337","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4811_CR26","doi-asserted-by":"crossref","unstructured":"Shimada M, Araya C, Rivard C, Ishimoto T, Johnson RJ, Garin EH (2011) Minimal change disease: a \u201ctwo-hit\u201d podocyte immune disorder?. Pediatric Nephrology 26 (4):645\u2013649","DOI":"10.1007\/s00467-010-1676-x"},{"key":"4811_CR27","doi-asserted-by":"publisher","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","volume":"3","author":"A Fornoni","year":"2011","unstructured":"Fornoni A, Sageshima J, Wei C, Merscher-Gomez S, Aguillon-Prada R, Jauregui AN, Li J, Mattiazzi A, Ciancio G, Chen L, Zilleruelo G, Abitbol C, Chandar J, Seeherunvong W, Ricordi C, Ikehata M, Rastaldi MP, Reiser J, Burke GW 3rd (2011) Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 3:85ra46","journal-title":"Sci Transl Med"},{"key":"4811_CR28","doi-asserted-by":"publisher","first-page":"e81836","DOI":"10.1172\/jci.insight.81836","volume":"2","author":"AH Kim","year":"2017","unstructured":"Kim AH, Chung JJ, Akilesh S, Koziell A, Jain S, Hodgin JB, Miller MJ, Stappenbeck TS, Miner JH, Shaw AS (2017) B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement. JCI Insight 2:e81836","journal-title":"JCI Insight"},{"key":"4811_CR29","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.kint.2019.05.031","volume":"96","author":"ET Chambers","year":"2019","unstructured":"Chambers ET, Gbadegesin RA (2019) Aberrant IgM on T cells: biomarker or pathogenic factor in childhood nephrotic syndrome? Kidney Int 96:818\u2013820","journal-title":"Kidney Int"},{"key":"4811_CR30","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nri2155","volume":"7","author":"DC Roopenian","year":"2007","unstructured":"Roopenian DC, Akilesh S (2007) FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 7:715\u2013725","journal-title":"Nat Rev Immunol"},{"key":"4811_CR31","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1007\/s00467-014-2860-1","volume":"29","author":"C Dossier","year":"2014","unstructured":"Dossier C, Sellier-Leclerc AL, Rousseau A, Michel Y, Gautheret-Dejean A, Englender M, Madhi F, Charbit M, Ulinski T, Simon T, Jacqz-Aigrain E, Deschenes G (2014) Prevalence of herpesviruses at onset of idiopathic nephrotic syndrome. Pediatr Nephrol 29:2325\u20132331","journal-title":"Pediatr Nephrol"},{"key":"4811_CR32","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1681\/ASN.2015050523","volume":"27","author":"M Colucci","year":"2016","unstructured":"Colucci M, Carsetti R, Cascioli S, Casiraghi F, Perna A, Rava L, Ruggiero B, Emma F, Vivarelli M (2016) B cell reconstitution after rituximab treatment in idiopathic nephrotic syndrome. J Am Soc Nephrol 27:1811\u20131822","journal-title":"J Am Soc Nephrol"},{"key":"4811_CR33","first-page":"151","volume":"390","author":"DA Thorley-Lawson","year":"2015","unstructured":"Thorley-Lawson DA (2015) EBV persistence--introducing the virus. Curr Top Microbiol Immunol 390:151\u2013209","journal-title":"Curr Top Microbiol Immunol"},{"key":"4811_CR34","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1681\/ASN.2014030247","volume":"26","author":"RA Gbadegesin","year":"2015","unstructured":"Gbadegesin RA, Adeyemo A, Webb NJ, Greenbaum LA, Abeyagunawardena A, Thalgahagoda S, Kale A, Gipson D, Srivastava T, Lin JJ, Chand D, Hunley TE, Brophy PD, Bagga A, Sinha A, Rheault MN, Ghali J, Nicholls K, Abraham E, Janjua HS, Omoloja A, Barletta GM, Cai Y, Milford DD, O'Brien C, Awan A, Belostotsky V, Smoyer WE, Homstad A, Hall G, Wu G, Nagaraj S, Wigfall D, Foreman J, Winn MP (2015) HLA-DQA1 and PLCG2 are candidate risk loci for childhood-onset steroid-sensitive nephrotic syndrome. J Am Soc Nephrol 26:1701\u20131710","journal-title":"J Am Soc Nephrol"},{"key":"4811_CR35","doi-asserted-by":"crossref","unstructured":"Shiyue C, Zhi L, Junju H, Shujun F, Yumei D, Qin Z, Yuanliang Y, Xiaoyu L, Liyu L, Chang F, Lu Z, Jiang H, Yuezhen D, Lun-Quan S (2019) Epstein\u2013Barr virus noncoding RNAs from the extracellular vesicles of nasopharyngeal carcinoma (NPC) cells promote angiogenesis via TLR3\/RIG-I-mediated VCAM-1 expression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1865 (6):1201\u20131213","DOI":"10.1016\/j.bbadis.2019.01.015"},{"key":"4811_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jaut.2017.12.014","volume":"89","author":"A Jamin","year":"2018","unstructured":"Jamin A, Berthelot L, Couderc A, Chemouny JM, Boedec E, Dehoux L, Abbad L, Dossier C, Daugas E, Monteiro RC, Deschenes G (2018) Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice. J Autoimmun 89:149\u2013161","journal-title":"J Autoimmun"},{"key":"4811_CR37","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/apa.14582","volume":"108","author":"E Nattes","year":"2019","unstructured":"Nattes E, Karaa D, Dehoux L, Peuchmaur M, Kwon T, Deschenes G (2019) Remission of proteinuria in multidrug-resistant idiopathic nephrotic syndrome following immunoglobulin immunoadsorption. Acta Paediatr 108:757\u2013762","journal-title":"Acta Paediatr"},{"key":"4811_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41581-019-0148-1","volume":"15","author":"C Meyer-Schwesinger","year":"2019","unstructured":"Meyer-Schwesinger C (2019) The ubiquitin-proteasome system in kidney physiology and disease. Nat Rev Nephrol 15:393\u2013411","journal-title":"Nat Rev Nephrol"},{"key":"4811_CR39","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/path.2446","volume":"217","author":"C Meyer-Schwesinger","year":"2009","unstructured":"Meyer-Schwesinger C, Meyer TN, Munster S, Klug P, Saleem M, Helmchen U, Stahl RA (2009) A new role for the neuronal ubiquitin C-terminal hydrolase-L1 (UCH-L1) in podocyte process formation and podocyte injury in human glomerulopathies. J Pathol 217:452\u2013464","journal-title":"J Pathol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04811-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-020-04811-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04811-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:16:49Z","timestamp":1744165009000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-020-04811-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,28]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["4811"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04811-0","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,28]]},"assertion":[{"value":"3 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}